pillbase.ru

Qulipta

Active substance: atogepant

TABLET · ATOGEPANT 30 mg/1

United StatesActive

Marketing holder: AbbVie Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • КЬЮЛИПТА
    таблетки, 10 мг (original in Russian, GRLS)
    ЛП-№(006822)-(РГ-RU)
    Общество с ограниченной ответственностью "ЭббВи"
EU 1
  • Aquipta
    atogepant
    EMEA/H/C/005871
    AbbVie Deutschland GmbH & Co. KG
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-80db-7775-ae97-66e71c69fc97;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-8409-778d-b16e-b64a5738b20d,01a12093-3e7d-7b60-8b11-24c4626dbdd4,01a1209c-cf6a-7290-aadc-43fff9f71190;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0074-7096
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0074-7096 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0074-7096 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0074-7096 · Verified 2026-10-09 · open in source